Reports

Browse current and previous editions of Switzer Report

Monday Edition, 20 February 2023
Peter Switzer

How do we play this stock market twilight zone?

Peter Switzer · February 20, 2023

It seems like we’re in a stock market twilight zone and it’s hard to be categorical about whether this current trading period is a prelude to another leg up or another leg down. Here are my thoughts…

Featured posts Premium
Paul Rickard

Has CBA’s share price peaked?

Paul Rickard · February 20, 2023

The headline in The Australian Financial Review last Thursday summarised how many in the market were feeling in regard to CBA’s half year profit result – “as good as it gets”. Paul Rickard takes a closer look and asks: “has CBA’s share price peaked?

Markets Premium
Maureen Jordan

HOT stock: Telstra (TLS)

Maureen Jordan · February 20, 2023

For our “HOT” stock, Raymond Chan, Head of Asian Desk at Morgans explains that there are 4 key reasons why he likes Telstra (TLS)

Markets Premium
James Dunn

2 stocks under 10 cents

James Dunn · February 20, 2023

Can there possibly be good buying in single-digit share prices? I’ve been trawling through the ASX-listed population looking for this kind of situation, and here are two single-digit share prices that I think fit the bill

Shares Premium
Switzer on Saturday, 18 February 2023
Thursday Edition, 16 February 2023
Maureen Jordan

“HOT” stock: Orica (ORI)

Maureen Jordan · February 16, 2023

In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, says that the chart for Orica (ORI) is reflecting the potential for further upside.

Shares Premium
Paul Rickard

Questions of the Week

Paul Rickard · February 16, 2023

If I bought CBA shares this week, will I be eligible for the dividend, and how do I participate in the buy-back? Will CBA shares under the DRP be issued at a discount, and can I still change my participation? Is JB Hi-Fi a sell? What are the broker targets for Pilbara Minerals?

Question of the Week Premium
Tuesday Edition, 14 February 2023
Paul Rickard

Big LICs are still a sell and there are better alternatives

Paul Rickard · February 14, 2023

I feel like a bit of a “broken record” when it comes to listed investment companies (LICs) premiums and discounts. I have never understood why an investor would pay $1.20 for something that is worth $1.00. This is  what happens when investors choose to invest in listed investment companies trading at a premium to their NTA (net tangible asset value).

Markets Premium
James Dunn

4 biotechs with major news coming this year

James Dunn · February 14, 2023

The fact of biotech investing is that the share prices are at the mercy of news flow from drug trial results, partnerships with bigger companies, regulatory interactions and a wide range of other events that can point to the increased – or decreased – likelihood of the drug, medical device or diagnostic test ever reaching the market.

Shares Premium

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.